美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Decoy Therapeutics Inc

0.7422

-0.0562-7.04%

盤後：0.7113-0.0309-4.16%18:06 EST

成交量：9.42萬

成交額：7.14萬

市值：473.84萬

市盈率：-0.02

高：0.8000

開：0.7993

低：0.7400

收：0.7984

52周最高：34.65

52周最低：0.5148

股本：638.42萬

流通股本：634.11萬

量比：0.92

換手率：1.49%

股息：- -

股息率：- -

每股收益(TTM):-39.1909

每股收益(LYR):-86.9214

淨資產收益率：-139.55%

總資產收益率：-69.91%

市淨率：1.12

市盈率(LYR):-0.01

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Decoy Therapeutics參與虛擬投資者會議「這意味着什麼」環節，重點介紹近期宣佈的全球准入承諾協議

BUZZ-蓋茨基金會支持抗病毒藥物的獲取，誘餌治療公司（Decoy Therapeutics）崛起

Salarius Pharmaceuticals, Inc.盤中異動早盤股價大漲5.94%報0.567美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DCOY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DCOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","market":"US","secType":"STK","nameCN":"Decoy Therapeutics Inc","latestPrice":0.7422,"timestamp":1771621200000,"preClose":0.7984,"halted":0,"volume":94174,"hourTrading":{"tag":"盘后","latestPrice":0.7113,"preClose":0.7422,"latestTime":"18:06 EST","volume":2854,"amount":2061.2997,"timestamp":1771628805123,"change":-0.0309,"changeRate":-0.041633,"amplitude":0.080437},"delay":0,"changeRate":-0.07039078156312628,"floatShares":6341106,"shares":6384200,"eps":-39.1909,"marketStatus":"已收盤","change":-0.0562,"latestTime":"02-20 16:00:00 EST","open":0.7993,"high":0.799999,"low":0.74,"amount":71386.4723676,"amplitude":0.075149,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-39.1909,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":5,"adr":0,"listingDate":1422507600000,"exchange":"NASDAQ","adjPreClose":0.7984,"preHourTrading":{"tag":"盘前","latestPrice":0.7835,"preClose":0.7984,"latestTime":"09:09 EST","volume":1129,"amount":883.55208074,"timestamp":1771596581278,"change":-0.0149,"changeRate":-0.018662,"amplitude":0.070641},"postHourTrading":{"tag":"盘后","latestPrice":0.7113,"preClose":0.7422,"latestTime":"18:06 EST","volume":2854,"amount":2061.2997,"timestamp":1771628805123,"change":-0.0309,"changeRate":-0.041633,"amplitude":0.080437},"volumeRatio":0.919584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","floatShares":6341106,"roa":"-69.91%","roe":"-139.55%","lyrEps":-86.921415,"volumeRatio":0.919584,"shares":6384200,"dividePrice":0,"high":0.799999,"amplitude":0.075149,"preClose":0.7984,"low":0.74,"week52Low":0.5148,"pbRate":"1.12","week52High":34.65,"institutionHeld":0,"latestPrice":0.7422,"eps":-39.1909,"divideRate":0,"volume":94174,"delay":0,"ttmEps":-39.1909,"open":0.7993,"prevYearClose":0.6488,"prevWeekClose":0.7388,"prevMonthClose":0.7709,"prevQuarterClose":0.6488,"fiveDayClose":0.7501,"twentyDayClose":0.7505,"sixtyDayClose":0.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DCOY\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DCOY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DCOY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DCOY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DCOY","date":"2026-02-19","current":-0.018938,"percent":0.607143,"low":-1.594527,"twenty":-1.063103,"median":-0.983377,"eighty":-0.935898,"high":-0.790885,"avg":-1.014533,"sd":0.143486,"marketCap":4850697},"quantilePoints":[{"date":"2026-01-09","current":-0.982229,"twenty":-1.053663,"median":-1.026876,"eighty":-1.000088,"marketCap":4915816},{"date":"2026-01-16","current":-1.227403,"twenty":-1.203881,"median":-1.071522,"eighty":-1.040856,"marketCap":6142855},{"date":"2026-01-23","current":-0.957354,"twenty":-1.160688,"median":-1.045754,"eighty":-0.982229,"marketCap":4791324},{"date":"2026-01-30","current":-1.05749,"twenty":-1.109791,"median":-1.050666,"eighty":-0.994985,"marketCap":5292482},{"date":"2026-02-06","current":-0.790885,"twenty":-1.101882,"median":-1.039631,"eighty":-0.91832,"marketCap":3958189},{"date":"2026-02-13","current":-0.956844,"twenty":-1.071522,"median":-0.994921,"eighty":-0.926101,"marketCap":4788771},{"date":"2026-02-19","current":-0.969217,"twenty":-1.063103,"median":-0.983377,"eighty":-0.935898,"marketCap":4850697}],"updateTime":1771634998490},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DCOY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1146669991","title":"Decoy Therapeutics參與虛擬投資者會議「這意味着什麼」環節，重點介紹近期宣佈的全球准入承諾協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1146669991","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146669991?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 22:03","pubTimestamp":1770213795,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Inc（简称：Decoy Therapeutics）近日参与了虚拟投资者会议“这意味着什么”环节，重点展示了公司最新宣布的全球准入承诺协议。该环节旨在深入解读这一重要协议对公司的战略意义及潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"gpt_icon":0},{"id":"2603682867","title":"BUZZ-蓋茨基金會支持抗病毒藥物的獲取，誘餌治療公司（Decoy Therapeutics）崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2603682867","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603682867?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 21:25","pubTimestamp":1768310709,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4T3YE185:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"gpt_icon":0},{"id":"2601820407","title":"Salarius Pharmaceuticals, Inc.盤中異動 早盤股價大漲5.94%報0.567美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601820407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601820407?lang=zh_tw&edition=fundamental","pubTime":"2026-01-06 23:33","pubTimestamp":1767713625,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日23时33分，Salarius Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.94%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Pmgc Holdings Inc.、Cyclerion Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为1801.27%、1449.09%、228.72%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.，振幅分别为294.74%、161.40%、60.16%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106233346a6faf9f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106233346a6faf9f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCOY","BK4139","SLRX"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DCOY\",params:#limit:6,delay:false,,,undefined,":[]}}